ALX Oncology Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:ALXO Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
13 Jun 24	BuyUS$102,338	Peter Garcia	Individual	12,000	US$8.53
14 Mar 24	BuyUS$49,771	Jason Lettmann	Individual	4,400	US$11.31
12 Feb 24	SellUS$17,896,851	LSV Capital Management, LLC	Company	1,259,395	US$15.59
04 Jan 24	SellUS$36,957	Shelly Pinto	Individual	2,717	US$13.60
29 Dec 23	SellUS$24,530	Shelly Pinto	Individual	1,631	US$15.04
29 Dec 23	SellUS$107,972	Jaume Pons	Individual	7,179	US$15.04
29 Dec 23	SellUS$28,471	Peter Garcia	Individual	1,893	US$15.04
29 Dec 23	SellUS$47,045	Sophia Randolph	Individual	3,128	US$15.04
13 Dec 23	SellUS$4,101,290	LSV Capital Management, LLC	Company	317,988	US$13.19
06 Jul 23	SellUS$47,889	Shelly Pinto	Individual	7,345	US$6.52
30 Jun 23	SellUS$3,420	Shelly Pinto	Individual	466	US$7.34
30 Jun 23	SellUS$23,547	Jaume Pons	Individual	3,208	US$7.34
30 Jun 23	SellUS$11,781	Sophia Randolph	Individual	1,605	US$7.34
30 Jun 23	SellUS$6,511	Peter Garcia	Individual	887	US$7.34

Insider Buying: ALXO insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 27.5%.

Top 25 shareholders own 93.48% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
18.6%	venBio LLC	9,699,925	US$63.5m	0%	31.95%
14.4%	FMR LLC	7,522,809	US$49.3m	0.67%	no data
8.3%	Redmile Group, LLC	4,326,509	US$28.3m	18.2%	1.26%
8.1%	Vivo Capital, LLC	4,220,048	US$27.6m	0%	2.36%
6.03%	Cormorant Asset Management, LP	3,142,079	US$20.6m	0%	1.19%
5.66%	LSV Capital Management, LLC	2,949,580	US$19.3m	-29.9%	47.52%
5.22%	OrbiMed Advisors LLC	2,717,970	US$17.8m	-12.2%	0.26%
5.01%	Vestal Point Capital, LP	2,610,000	US$17.1m	57.7%	1.55%
4.26%	BlackRock, Inc.	2,221,561	US$14.6m	-0.61%	no data
3.01%	The Vanguard Group, Inc.	1,566,464	US$10.3m	4.26%	no data
2.88%	HBM Partners Ltd.	1,500,000	US$9.8m	0%	1.05%
2.43%	BioImpact Capital LLC	1,268,471	US$8.3m	0.29%	1.51%
2.37%	Citadel Advisors LLC	1,235,215	US$8.1m	0.17%	0.01%
1.16%	Geode Capital Management, LLC	604,714	US$4.0m	3.36%	no data
1.06%	State Street Global Advisors, Inc.	553,867	US$3.6m	10.4%	no data
0.86%	Jaume Pons	450,080	US$2.9m	-8.93%	no data
0.73%	Invesco Capital Management LLC	377,911	US$2.5m	0%	no data
0.47%	Sophia Randolph	247,474	US$1.6m	-4.62%	no data
0.47%	Northern Trust Global Investments	245,212	US$1.6m	0.56%	no data
0.45%	Renaissance Technologies LLC	234,100	US$1.5m	-13.5%	no data
0.45%	T. Rowe Price Group, Inc.	232,769	US$1.5m	-57.2%	no data
0.4%	Charles Schwab Investment Management, Inc.	209,759	US$1.4m	0.77%	no data
0.39%	Federated Hermes, Inc.	201,362	US$1.3m	2.46%	no data
0.38%	Eaton Vance Management	196,724	US$1.3m	-5.91%	no data
0.32%	Corey Goodman	167,370	US$1.1m	0%	no data